Home

Jan18-hero-cover-1366x768.jpg

Biophysical Characterization of Biopharmaceutical Products

Member Spotlight

MemberSpot

Meaningful Career, Lifelong Friends

After 30 years in the industry, Eric Fluhler values the strong relationships he has built the most. 

Beginning in pharmacokinetics and modeling before expanding into regulated bioanalysis, Fluhler's doctorate in biophysical chemistry gave him a broad enough base to contribute in both areas. 

Read More

Annual Meeting Digest

AMDigestHome

2017 AAPS Annual Meeting and Exposition Covers Science, Community, and Career

Science sessions highlight regenerative engineering, pediatric research policies, nanomedicine regulations, and CAR-T therapies.

A review of the annual meeting's plenary speakers and some of the science sessions.

Read More

Pharmaceutical Science Update

Posted By Linda Brown
Found In Microsite: AAPS News Magazine
On Jan. 12, the Food and Drug Administration (FDA) approved an expanded use of AstraZeneca's Lynparza (olaparib) to include treating patients with certain types of metastasized breast cancer, whose tumors have an inherited genetic mutation known as BRCA. ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
For the first time, researchers at the University of North Carolina at Chapel Hill (UNC) have isolated the brain receptors that trigger pain relief from the ones that cause side effects they said are at the heart of the opioid epidemic. More than 90 Americans ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
January 17, 2018 Novo Nordisk Inc. could not convince the Food and Drug Administration (FDA) to block abbreviated approval of generic competition to its liraglutide-based diabetes and weight loss drugs. Novo's citizen petition asking FDA not to approve ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
“This bill will lift the veil of secrecy by requiring federal agencies to post regulatory guidance documents in a centralized location of their websites,” said Ron Johnson (R-Wis.), chairman of the Senate Homeland Security and Governmental Affairs Committee, ...
Posted By Linda Brown
Found In Microsite: AAPS News Magazine
January 10, 2018 The Food and Drug Administration  (FDA) is taking additional steps to encourage generic competition as a way to lower drug prices. An FDA draft guidance and manual released on Jan. 3 (83 Fed. Reg. 532) are intended to streamline and ...

Pharmaceutical News

Please check back later for new Pharmaceutical News